Teva Pharmaceutical Industries Ltd

TEVA

Company Profile

  • Business description

    Teva Pharmaceutical Industries, based in Israel, is the leading generic drug manufacturer in the world. Teva derives half of its sales from North America and makes up a high-single-digit percentage of the total number of generic prescriptions in the US. It also has a significant presence in Europe, Japan, Russia, and Israel. Besides generics, Teva has a portfolio of innovative medicines and biosimilars in three main therapeutic areas: the central nervous system with Copaxone, Ajovy, and Austedo; respiratory with Qvar and ProAir; and oncology with Truxima, Herzuma, and Bendeka/Treanda. Teva also sells active pharmaceutical ingredients, offers contract manufacturing services, and owns Anda, a US-based generic and specialty drug distributor.

  • Contact

    124 Dvora HaNevi’a Street
    Tel Aviv6944020
    ISR

    T: +972 39148213

    E: TevaIR@Tevapharm.com

    https://www.tevapharm.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Drug Manufacturers - Specialty & Generic

    Fiscal Year End

    31 December 2025

    Employees

    35,686

Stocks News & Analysis

stocks

4 stocks in Buffett's portfolio

These undervalued stocks are among the holdings in Berkshire Hathaway today.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,021.9060.200.76%
CAC 407,285.8644.11-0.60%
DAX 4021,205.86105.16-0.49%
Dow JONES (US)39,142.23527.16-1.33%
FTSE 1008,275.660.060.00%
HKSE21,395.14338.161.61%
NASDAQ16,286.4520.71-0.13%
Nikkei 22534,730.28352.681.03%
NZX 50 Index12,118.9951.070.42%
S&P 5005,282.707.000.13%
S&P/ASX 2007,819.1060.200.78%
SSE Composite Index3,280.344.340.13%

Market Movers